Stock Events

Stock Events

H. Lundbeck AS 

0
142
+$0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

25AprExpected
Q3 2024
Q1 2025
Q3 2025
Q1 2026
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

Financials

12.85%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
3.79BRevenue
487.53MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow HLBBY. It's not an investment recommendation.
Novo Nordisk
34
NOVO-B.CO
Amper SA
16
AMP.MC
Alphabet
15
GOOGL
Nueva Expresion Textil.
15
NXT.MC

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap159.36B
Pfizer is a global pharmaceutical company that competes with Lundbeck in the development and marketing of drugs for psychiatric and neurological disorders.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson, through its Janssen Pharmaceuticals division, competes in the same therapeutic areas as Lundbeck, including mental health.
Novartis
NVS
Mkt Cap292.35B
Novartis offers products in neurology and psychiatry, directly competing with Lundbeck's portfolio.
Lilly(Eli) &
LLY
Mkt Cap1.05T
Eli Lilly has a strong presence in the psychiatric medication market, making it a direct competitor to Lundbeck.
Merck
MRK
Mkt Cap366B
Merck & Co. competes with Lundbeck in the area of brain health, including treatments for neurological conditions.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap42.46B
Teva Pharmaceutical Industries has a broad portfolio that includes CNS (central nervous system) drugs, competing with Lundbeck.
Abbvie
ABBV
Mkt Cap451.46B
AbbVie, with its neuroscience division, offers products that compete in the same space as Lundbeck's treatments.
Bristol-Myers Squibb
BMY
Mkt Cap136B
Bristol Myers Squibb has a range of psychiatric and neurological drugs, positioning it as a competitor to Lundbeck.
Astrazeneca
AZN
Mkt Cap252.33B
AstraZeneca operates in various therapeutic areas, including those that overlap with Lundbeck's CNS focus.
GSK
GSK
Mkt Cap101.78B
GlaxoSmithKline has a diversified portfolio that includes medications for mental health, competing with Lundbeck.

About

H LUNDBECK A/S U/ADR A
Show more...
CEO
Deborah Dunsire
Country
United States
ISIN
US40422M4042

Listings

MU
DE
LDBA.MU
Grey Market
US
LDBMF
STU
DE
LDBA.STU
MU
DE
LDB.MU

0 Comments

Share your thoughts

FAQ

What is H. Lundbeck AS stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange H. Lundbeck AS stocks are traded under the ticker HLBBY.
What is H. Lundbeck AS revenue for the last year?▼
H. Lundbeck AS revenue for the last year amounts to 3.79B USD.
What is H. Lundbeck AS net income for the last year?▼
HLBBY net income for the last year is 487.53M USD.
In which sector is H. Lundbeck AS located?▼
H. Lundbeck AS operates in the Technology sector.
When did H. Lundbeck AS complete a stock split?▼
H. Lundbeck AS has not had any recent stock splits.
Where is H. Lundbeck AS headquartered?▼
H. Lundbeck AS is headquartered in Ottiliavej 9, United States.